XTL Biopharmaceuticals (XTAE:XTLB) EV-to-FCF: (As of Aug. 01, 2026)

XTL Biopharmaceuticals  (XTAE:XTLB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

XTL Biopharmaceuticals's PE Ratio (TTM) for today is calculated as:

XTL Biopharmaceuticals's share price for today is ₪0.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XTL Biopharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₪-0.024.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

XTL Biopharmaceuticals EV-to-FCF Related Terms

The historical data trend for XTL Biopharmaceuticals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XTL Biopharmaceuticals EV-to-FCF Chart

XTL Biopharmaceuticals Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-FCF		Get a 7-Day Free Trial					-8.74	-3.97	-5.97	-10.59	-7.35

XTL Biopharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
EV-to-FCF	Get a 7-Day Free Trial															-5.97	0.00	-10.59	0.00	-7.35

XTAE:XTLB vs VRTX, REGN, RVMD: EV-to-FCF Comparison

For the Biotechnology subindustry, XTL Biopharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XTL Biopharmaceuticals EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XTL Biopharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where XTL Biopharmaceuticals's EV-to-FCF falls into.

XTL Biopharmaceuticals EV-to-FCF Calculation

XTL Biopharmaceuticals's EV-to-FCF for today is calculated as:

XTL Biopharmaceuticals's current Enterprise Value is ₪20.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XTL Biopharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was ₪0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XTL Biopharmaceuticals Business Description